Table 1.
Target volumes dosimetric comparison mean values.
| V95%PTV1 | V105%PTV1 | V95%PTV2 | V100%PTV2 | V105%PTV2 | HI PTV1 | HI PTV2 | |
|---|---|---|---|---|---|---|---|
| Tri-Co-60 Bon | 98.9 | 0.14 | 98.0 | 55.8 | 14.7 | 7.0% | 20% |
| Range (97.4–99.6) | Range (0–0.4) | Range (97.4–98.5) | Range (55.83–64.86) | Range (7.12–21) | Range (5–9) | Range (16–21) | |
| SD ± 0.78% | SD ± 0.15% | SD ± 0.4% | SD ± 3.33% | SD ± 5.47% | SD ± 1% | SD ± 2% | |
| Tri-Co-60 Boff | 99.2 | 0.0 | 98.2 | 62.0 | 14.8 | 7.4% | 20.04% |
| Range (98.7–99.7) | Range (0.0) | Range (97.6–98.8) | Range (59.1–66) | Range (6.76–20.9) | Range (6.8–8) | Range (16.07–22.09) | |
| SD ± 0.39% | SD 0.0% | SD ± 0.46% | SD ± 2.7% | SD ± 5.9% | SD ± 0.41% | SD ± 2.07% | |
| VMAT | 97.8 | 0.0 | 98.4 | 47.3 | 5.0 | 7.82% | 13.26% |
| Range (95.7–99) | Range (0.0) | Range (95.8–99.5) | Range (42.9–57.6) | Range (1.36–8.6) | Range (6.8–8.7) | Range (8.29–17.30) | |
| SD ± 1.15% | SD 0.0% | SD ± 1.29% | SD ± 6.44% | SD ± 2.8% | SD ± 0.72% | SD ± 3.29% | |
| IMRT | 98.2 | 0.1 | 97.7 | 54.8 | 7.3 | 7.72% | 14.69% |
| Range (97–99) | Range (0–0.96) | Range (95.3–99.9) | Range (47.6–68.5) | Range (1.31–10.43) | Range (6.7–9.3) | Range (5.35–19.80) | |
| SD ± 0.76% | SD ± 0.35% | SD ± 1.58% | SD ± 7.1% | SD ± 3.31% | SD ± 0.96% | SD ± 4.76% | |
Legend: VMAT: Volumetric Modulated Arc Therapy; IMRT: Intensity Modulated Radiation Therapy; Tri-Co-60 IMRT-MRI: 60 Cobalt-Magnetic Resonance Imaging; Bon: with magnetic field presence; Boff: without magnetic field presence; HI: Homogeneity index; PTV: Planning Target Volume; Gy: Gray; SD: standard deviation.